Showing results (981-990 of 1,019) with videos related to
Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|October 29, 2025
The HIV Epidemic in the United States - Epidemiological Projections and Public Economic Impact of Achieving Zero Transmission GoalsCillian Copeland, Rui Martins, Ryan Thaliffdeen, et al.Clinicoeconomics and Outcomes Research : CEOR|July 18, 2025
Comparative Cost Analysis for Direct Medical Costs of Protocol Administration of Non-Small Cell Lung Cancer Treatment Regimens in Curative Intent: A Micro-Costing Study in JordanSaba S Madae'en, Ahmed A Salem, Naila S Ararawi, et al.Clinicoeconomics and Outcomes Research : CEOR|July 24, 2025
Healthcare Costs and Treatment Patterns of Triplet Therapies in Relapsed/Refractory Multiple Myeloma: Real World Evidence from ItalyValentina Perrone, Melania Leogrande, Elisa Giacomini, et al.Clinicoeconomics and Outcomes Research : CEOR|July 29, 2025
Enhancing Patient Safety and Charge Capture Through Smart Infusion Pump Interoperability: A Health Economic Analysis for US Health SystemsEric P Borrelli, Ashley Taneja, Shafiq Abdallah, et al.Clinicoeconomics and Outcomes Research : CEOR|June 23, 2025
Medicare Savings for Seizure Drugs by Adopting the Mark Cuban Cost Plus Drug Company ModelTim Smith, Alec Young, Cameron O'Brien, et al.Clinicoeconomics and Outcomes Research : CEOR|June 19, 2025
The Economic Burden of Patients with Diabetic Peripheral Neuropathic Pain Based on a Real-World Study in ChinaRosa Wang, Dennis D Xuan, Jianwei Xuan, et al.Clinicoeconomics and Outcomes Research : CEOR|February 14, 2024
Pharmacoeconomic Evaluation of Costs of Myelomeningocele and Meningocele Treatment and ScreeningMalvina Hoxha, Visar Malaj, Bruno Zappacosta, et al.Clinicoeconomics and Outcomes Research : CEOR|March 13, 2024
Medical Costs Associated with High/Moderate/Low Likelihood of Adult Growth Hormone Deficiency: A Healthcare Claims Database AnalysisKevin C J Yuen, Lewis S Blevins, David R Clemmons, et al.Clinicoeconomics and Outcomes Research : CEOR|April 1, 2024
Evaluating Health Expenditure Trends and Disease Burden in India: A Cost per DALY ApproachBhavani Shankara Bagepally, Sajith Kumar S, Akhil SasidharanClinicoeconomics and Outcomes Research : CEOR|April 1, 2024
Racial and Ethnic Differences in Initiation and Discontinuation of Antiarrhythmic Medications in Management of Atrial FibrillationRyan Kipp, Lee-Or Herzog, Rahul Khanna, et al.Pageof 102